Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study

被引：0
|
作者：
Li Ying
Ji Suyun
Liang Yanhua
Liang Yunsheng
Deng Li
Dang Lin
Lv Chengzhi
Lin Bingjiang
Zhang Furen
Shi Wendi
Li Jinnan
Dong Yu
Dou Guanshen
Yuling Shi
机构：
[1] Tongji University School of Medicine,Department of Dermatology, Shanghai Skin Disease Hospital
[2] Southern Medical University,Department of Dermatology, Dermatology Hospital
[3] Southern Medical University,Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital
[4] Longgang Central Hospital of Shenzhen,Department of Dermatology
[5] Dalian Skin Disease Hospital,Department of Dermatology
[6] Ningbo First Hospital,Department of Dermatology
[7] Shandong First Medical University & Shandong Academy of Medical Sciences,Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology
[8] Eli Lilly and Company,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Efficacy; Ixekizumab; Psoriasis; Real world; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5464 / 5474
页数：10
相关论文
共 50 条
  • [1] Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
    Ying, Li
    Suyun, Ji
    Yanhua, Liang
    Yunsheng, Liang
    Li, Deng
    Lin, Dang
    Chengzhi, Lv
    Bingjiang, Lin
    Furen, Zhang
    Wendi, Shi
    Jinnan, Li
    Yu, Dong
    Guanshen, Dou
    Shi, Yuling
    ADVANCES IN THERAPY, 2023, 40 (12) : 5464 - 5474
  • [2] Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
    Andrea Chiricozzi
    Martina Burlando
    Giacomo Caldarola
    Andrea Conti
    Giovanni Damiani
    Clara De Simone
    Valentina Dini
    Piergiorgio Malagoli
    Francesca Peccerillo
    Concetta Potenza
    Emanuele Scala
    Nevena Skroza
    Anna Balato
    American Journal of Clinical Dermatology, 2020, 21 : 441 - 447
  • [3] Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
    Chiricozzi, Andrea
    Burlando, Martina
    Caldarola, Giacomo
    Conti, Andrea
    Damiani, Giovanni
    De Simone, Clara
    Dini, Valentina
    Malagoli, Piergiorgio
    Peccerillo, Francesca
    Potenza, Concetta
    Scala, Emanuele
    Skroza, Nevena
    Balato, Anna
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (03) : 441 - 447
  • [4] The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study
    Li, Ying
    Dang, Lin
    Lv, Chengzhi
    Lin, Bingjiang
    Tao, Juan
    Yu, Nan
    Deng, Ya
    Wang, Huiping
    Kang, Xiaojing
    Qin, Hui
    Chen, Rong
    Li, Jinnan
    Liang, Yunsheng
    Liang, Yanhua
    Shi, Yuling
    DRUG SAFETY, 2024, 47 (07) : 711 - 719
  • [5] Efficacy and Safety of Ixekizumab in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis
    Paller, Amy
    Seyger, Marieke
    Alejandro Magarinos, Gabriel
    Bagel, Jerry
    Keller, Stuart
    Capriles, Claudia Rodriguez
    Gallo, Gaia
    Edson-Heredia, Emily
    Li, Lingnan
    Xu, Wen
    Papp, Kim
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 17 - 17
  • [6] Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis
    Vu, Trang T.
    Gooderham, Melinda
    Papp, Kim
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (11) : 1423 - 1433
  • [7] Efficacy and safety of ixekizumab in Chinese patients with moderate-to-severe plaque psoriasis: 12-week results from a phase 3 study
    Rui, Wenlong
    Li, Xia
    Zheng, Jie
    Pan, Weili
    Zheng, Min
    Lu, Yan
    Li, Fuqiu
    Ding, Yangfeng
    Zhang, Jianzhong
    Li, Hongying
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB55 - AB55
  • [8] Efficacy and Safety of Ixekizumab in Chinese Patients With Moderate-to-Severe Plaque Psoriasis: 60-Week Results From a Phase 3 Study
    Li Xia
    Zheng Jie
    Pan WeiLi
    Zheng Min
    Lu Yan
    Li FuQiu
    Ding YangFeng
    Zhang JianZhong
    Li HongYing
    Rui WenLong
    国际皮肤性病学杂志（英文）, 2022, 05 (04)
  • [9] Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and comorbid diabetes mellitus
    Egeberg, A.
    Schaekel, K.
    Puig, L.
    Saure, D.
    Yali Wang, I.
    Pavo, I.
    Mahar, P.
    Schuster, C.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E31 - E31
  • [10] Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study
    Min Zheng
    Xiang Chen
    Feng Wang
    Jisu Chen
    Kimberley Jackson
    Fan Yang
    Christopher Payne
    HongYing Li
    YiHui Wang
    ZiPei Xiao
    Jie Zheng
    Advances in Therapy, 2023, 40 : 3804 - 3816
12345